PUBBLICATO IL NUMERO 4 DELLA WHO PHARMACEUTICAL NEWSLETTER



WHO PHARMACEUTICALS NEWSLETTER, N. 4
Fonte: WHO. Agosto 2010



E' disponibile il numero 4 della WHO PHARMACEUTICALS NEWSLETTER dell'Organizzazione Mondiale della Sanità.

In questo numero sono trattati i seguenti argomenti:
Regulatory Matters
• Dextropropoxyphene
• Gemtuzumab ozogamicin
• Leflunomide
• Long-Acting Beta-Agonists
• Omeprazole
• Orlistat
• Proton pump inhibitors
• Quinine
• Seasonal trivalent influenza vaccination
• Sodium valproate and carbapenems
• Tramadol
• Varenicline tartrate
Safety of Medicines
• Acitretin
• Angiotensin Receptor Blockers..
• H1N1 pandemic vaccines and antiviral.
• Intravenous paracetamol
• Methylphenidate.
• Olmesartan
• Pregabalin
• Rivastigmine transdermal patch
• Zoledronic acid
• Fraudulent Tamiflu
Feature
• Workshop on Pharmaceutical Development of Paediatric Formulations
• HSA hosts the First Pharmacovigilance Training for ASEAN Countries
• Seventh Meeting of the WHO Advisory Committee on Safety of Medicinal Products